SEC Form 4 research
| Issuer | Inhibikase Therapeutics, Inc. |
|---|---|
| Tickers | IKT |
| Reporting owners | 25 |
| Officers and directors | 5 |
| Last public filing | 2026-10-21 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-21 | 2026-10-19 | Wasserman Scott M. | A | 310,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.